Cite
HARVARD Citation
He, J. et al. (2018). Expression of Programmed Death Ligand 1 (PD-L1) in Posttreatment Primary Inflammatory Breast Cancers and Clinical Implications. American journal of clinical pathology. 149 (3), pp. 253-261. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
He, J. et al. (2018). Expression of Programmed Death Ligand 1 (PD-L1) in Posttreatment Primary Inflammatory Breast Cancers and Clinical Implications. American journal of clinical pathology. 149 (3), pp. 253-261. [Online].